Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

"I want to leave an impact on the Dover basketball program ... for all of the younger girls playing," Lilly Nossif says after setting scoring record.

Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Eli Lilly & Co (LLY – Research Report) today and set a price ...

We recently published a list of 10 Important News Updates Investors Shouldn’t Miss. In this article, we are going to take a ...

The stock's fall snapped a four-day winning streak.

We recently compiled a list of the 13 Best Dividend Growth Stocks With 10%+ Yearly Increases. In this article, we are going ...

Alphabet and Amazon.com were the latest among Magnificent Seven tech stocks to fall short of guidance forecasts, weighing on ...

Maddi Reese is asked to remix one thing about each of her castmates from Southern Hospitality. She says she would get Emmy ...

The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...

Eli Lilly's profit doubled in the fourth quarter, propelled by its hot-selling diabetes and obesity treatments, and the ...

Roblox stock is down Thursday after the gaming company came up short on key metrics for its fourth quarter. Here's what you ...

Stay updated on the latest stock market trends and company earnings. Discover the impact of market gains and profit reports ...